ATE266632T1 - Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen - Google Patents

Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen

Info

Publication number
ATE266632T1
ATE266632T1 AT02722661T AT02722661T ATE266632T1 AT E266632 T1 ATE266632 T1 AT E266632T1 AT 02722661 T AT02722661 T AT 02722661T AT 02722661 T AT02722661 T AT 02722661T AT E266632 T1 ATE266632 T1 AT E266632T1
Authority
AT
Austria
Prior art keywords
compositions containing
dietary
containing same
therapeutic use
creatine salt
Prior art date
Application number
AT02722661T
Other languages
English (en)
Inventor
Antonietta Buononato
Original Assignee
Biosalts Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosalts Srl filed Critical Biosalts Srl
Application granted granted Critical
Publication of ATE266632T1 publication Critical patent/ATE266632T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02722661T 2001-03-23 2002-03-19 Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen ATE266632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000155A ITRM20010155A1 (it) 2001-03-23 2001-03-23 Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.
PCT/IT2002/000170 WO2002076931A1 (en) 2001-03-23 2002-03-19 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same

Publications (1)

Publication Number Publication Date
ATE266632T1 true ATE266632T1 (de) 2004-05-15

Family

ID=11455369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722661T ATE266632T1 (de) 2001-03-23 2002-03-19 Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen

Country Status (13)

Country Link
US (1) US6861554B2 (de)
EP (1) EP1292570B1 (de)
CN (1) CN1460102A (de)
AT (1) ATE266632T1 (de)
CA (1) CA2408528C (de)
DE (1) DE60200476T2 (de)
DK (1) DK1292570T3 (de)
ES (1) ES2219633T3 (de)
IT (1) ITRM20010155A1 (de)
MX (1) MXPA02011465A (de)
PT (1) PT1292570E (de)
TR (1) TR200401701T4 (de)
WO (1) WO2002076931A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
DE10208568A1 (de) * 2002-02-27 2003-09-18 Degussa Bioactives Deutschland Verbindung, enthaltend Kreatin, eine Säure-Komponente und/oder einen Komplex-Bildner
US20040186782A1 (en) * 2003-03-21 2004-09-23 Andrew Schydlowsky Custom food
ITRM20040143A1 (it) * 2004-03-19 2004-06-19 Biosalts Srl Sale di creatina ad aumentato valore nutrizionale e terapeutico e composizioni che lo contengono.
JP5119509B2 (ja) * 2006-05-18 2013-01-16 ビーエイチエヌ株式会社 活動意欲向上剤
US7329763B1 (en) * 2006-09-11 2008-02-12 New Cell Formulations Ltd Creatine pyroglutamic acid salts and methods for their production and use in individuals
WO2008031212A1 (en) * 2006-09-11 2008-03-20 New Cell Formulations Ltd. Creatine pyroglutamic acid salts and methods for their production and use in individuals
US20080153897A1 (en) * 2006-09-11 2008-06-26 New Cell Formulations Ltd. Creatine pyroglutamic acid salts and methods for their production and use in individuals
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
US20120010291A1 (en) * 2009-08-12 2012-01-12 Kneller Bruce W CREATINE Beta-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
US20090312419A1 (en) * 2009-08-12 2009-12-17 Kneller Bruce W CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
DK0969744T3 (da) * 1997-03-27 2003-06-23 Khursheed N Jeejeebhoy Kosttilskud til forbedringer af celleenergetik
IT1306186B1 (it) * 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale

Also Published As

Publication number Publication date
CA2408528A1 (en) 2002-10-03
ES2219633T3 (es) 2004-12-01
DE60200476D1 (de) 2004-06-17
WO2002076931A1 (en) 2002-10-03
MXPA02011465A (es) 2004-02-26
DK1292570T3 (da) 2004-09-13
US20030180276A1 (en) 2003-09-25
PT1292570E (pt) 2004-09-30
EP1292570B1 (de) 2004-05-12
ITRM20010155A0 (it) 2001-03-23
US6861554B2 (en) 2005-03-01
CA2408528C (en) 2010-04-20
CN1460102A (zh) 2003-12-03
DE60200476T2 (de) 2005-05-25
TR200401701T4 (tr) 2004-08-23
ITRM20010155A1 (it) 2002-09-23
EP1292570A1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
CY1109503T1 (el) Συνθεσεις βρεφικων τροφων που περιλαμβανουν αυξημενες ποσοτητες αλφα-λακταλβουμινης
ATE494275T1 (de) Herstellung von cis-pellitorin und verwendung als aromastoff
ATE231872T1 (de) Thiazolopyrimidinderivate
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
ATE250566T1 (de) 24-hydroxy vitamin d, deren analogen und verwendungen
ATE266632T1 (de) Kreatin-salz mit nahrungs- und therapeutischer verwendung und dieses enthaltende zusammensetzungen
DE60330542D1 (de) Pharmazeutische Zubereitung enthaltend einen NMDA Rezeptor Agonisten für die Behandlung von Bewegungsstörungen
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
IL178727A0 (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse
BR0213536A (pt) Formulações de xarope de ribavirina
SE0300457D0 (sv) Novel compounds
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
FI20021822A0 (fi) Elintarvike
IS2597B (is) Lyf samsett úr R,R-formóteróli og siklesóníði
DK1289931T3 (da) Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende samme
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
ATE291468T1 (de) Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.
BRPI0410638A (pt) derivados de azitromicina
ITRM20010029A0 (it) Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
WO2005089734A3 (en) Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same
ITRM20010493A1 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.
DE60319873D1 (de) Modifizierte guanosine mit geschmackwirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292570

Country of ref document: EP

REN Ceased due to non-payment of the annual fee